Associations of leisure-time physical activity and obesity with atherogenic lipoprotein-lipid markers among non-smoking middle-aged men

Scandinavian Journal of Medicine and Science in Sports

Volumn 11, Issue 1, 2001, Pages 38-46

  Carroll, S ^a   Cooke, C B ^a   Butterly, R J ^a   Gately, P ^a  

^a LEEDS METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

High density lipoprotein; Non high density lipoprotein; Triglycerides

Indexed keywords

BIOLOGICAL MARKER; LIPID; LIPOPROTEIN;

ADULT; ARTICLE; BLOOD; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; FITNESS; HUMAN; LIFESTYLE; MALE; MIDDLE AGED; OBESITY; RISK FACTOR;

ACTIVITIES OF DAILY LIVING; ADULT; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; HUMANS; LIFE STYLE; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; OBESITY; PHYSICAL FITNESS; RISK FACTORS;

EID: 0035261077     PISSN: 09057188     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0838.2001.011001038.x     Document Type: Article

References (48)

1. Alberti KGMM, Zimmet PZ, for the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 1998: 15: 539-553.
2. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1998: 21(Suppl 1): S5-S19.
3. Anderssen SA, Holme I, Urdal P, Hjermann I. Associations between central adiposity and indexes of hemostatic, carbohydrate and lipid metabolism. Results of a 1-year intervention form the Oslo Diet and Exercise Study. Scand J Med Sci Sports 1998: 8: 109-115.
4. Assanelli D, Bersatti F, Ferrari R, Bollani G, Ferrari M, Ballardini E, Guerra GP, Parrinello G. Effect of leisure time and working activity on principal risk factors and relative interactions in active middle-aged men. Coron Artery Dis 1999: 10: 1-7.
5. Astrand PO, Rodahl K. Textbook of work physiology: Physiological basis of exercise. 3rd edn. New York: McGraw-Hill, 1986: 354-390.
6. Barham D, Trinder P. An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst 1972: 97: 142-145.
7. Blair SN, Cooper KH, Gibbons LW, Gettman LR, Lewis S, Goodyear N. Changes in coronary heart disease risk factors associated with increased treadmill time in 753 men. Am J Epidemiol 1983: 118: 352-359.
8. Boer JM, Feskens EJ, Schouten EG, Havekes LM, Seidell JC, Kromhout D. Lipid profiles reflecting high and low risk for coronary heart disease: contribution of apolipoprotein E polymorphism and lifestyle. Atherosclerosis 1998: 136: 395-402.
9. Castelli WP. The new pathophysiology of coronary artery disease. Am J Cardiol 1998: 82 (10B): 60T-65T.
10. Connelly PW, Petrasovitis A, Stachenko S, MacLean DR, Little JA, Chockalingam A. Prevalence of high plasma triglycerides combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C in the Canadian population. Can J Cardiol 1999a: 15: 428-433.
11. Connelly PW, Poapst M, Davignon J, Lussier-Calan S, Reeder S, Hegele RA, Csima A. Reference values of plasma apolipoproteins A-1 and B and association with non-lipid risk factors in the populations of two Canadian provinces: Quebec and Saskatchewan. Canadian Heart Health Survey Research Group. Can J Cardiol 1999b: 15: 409-418.
12. Coon PJ, Bleecker ER, Drinkwater DT, Meyers DA, Goldberg AP. Effects of body composition and exercise capacity on glucose tolerance, insulin, and lipoprotein lipids in healthy older men: a cross-sectional and longitudinal intervention study. Metabolism 1989: 38: 1201-1209.
13. Criqui MH, Golomb BA. Epidemiological aspects of lipid abnormalities. Am J Med 1998: 105 (1A): 48S-57S.
14. Cullen P, Schulte H, Assman G. Smoking, lipoproteins and coronary heart disease risk. Data from the Munster Heart Study (PROCAM). Eur Heart J 1998: 19: 1632-1641.
15. Després JP. Dyslipidemia and obesity. Ballieres Clin Endocrinol Metab 1994: 8: 629-660.
16. Després, JP. Visceral obesity, insulin resistance, and dyslipidemia: contribution of endurance exercise training to the treatment of the plurimetabolic syndrome. Exerc Sport Sci Rev 1997: 25: 271-300.
17. Donahue RP, Orchard TJ, Becker DJ, Kuller LH, Drash AL. Physical activity, insulin sensitivity, and the lipoprotein profile in young adults: the Beaver County Study. Am J Epidemiol 1988: 127: 95-103.
18. Durnin, JVGA, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness measurements on 481 men and women aged 16-72 years. Br J Nutr 1974: 32: 77-85.
19. Durstine JL, Haskell WL. Effects of exercise training on plasma lipids and lipoproteins. In: Holloszy JO (ed). Exercise and Sport Science Reviews. Baltimore: Williams and Wilkins, 1994: 477-521.
20. Elwood PC, Yarnell JWG, Pickering J, Fehily AM, O'Brien JR. Exercise, fibrinogen and other risk factors for ischaemic heart disease. Caerphilly Prospective Heart Disease Study. Br Heart J 1993: 69: 183-187.
21. Erikkson J, Taimela S, Koivisto VA. Exercise and the metabolic syndrome. Diabetologia 1997: 40: 125-135.
22. Fonong T, Toth MJ, Ades PA, Katzel LI, Calles-Escandon J, Poehlman ET. Relationship between physical activity and HDL-cholesterol in healthy older men and women: a cross-sectional and exercise intervention study. Atherosclerosis 1996: 127: 177-183.
23. Frost PH, Havel RJ. Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy. Am J Cardiol 1998: 81(4A): 26B-31B.
24. Gaziano JM, Hennekens CH, O'Donnell CJ. Fasting triglycerides, high density lipoprotein, and risk of myocardial infarction Circulation 1997: 96: 2520-2525.
25. Grundy SM. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome Am J Cardiol 1998: 81(4A): 18B-25B.
26. Houmard JA, Wheeler WS, McCammon MR, Holbert D, Israel RG, Barakat HA. Effects of fitness level and regional distribution of fat on carbohydrate metabolism and plasma lipids in middle-to-older-aged men. Metabolism 1991: 40: 714-719.
27. Hunter GR, Kekes-Szabo T, Snyder SW, Nicholson C, Nyikos I, Berland L. Fat distribution, physical activity and cardiovascular risk factors. Med Sci Sports Exerc 1997: 29: 362-369.
28. Jacobs DR. Jr, Ainsworth BE, Hartman TJ, Leon AS. A simultaneous evaluation of 10 commonly used physical activity questionnaires. Med Sci Sports Exerc 1993: 25: 81-91.
29. Lakka TA, Salonen JT. Physical activity and serum lipids: a cross-sectional population study in eastern Finnish men. Am J Epidemiol 1992: 136: 806-818.
30. Lamarche B, Lewis GF. Atherosclerosis prevention for the next decade: risk assessment beyond low density lipoprotein cholesterol. Can J Cardiol 1998: 14: 841-851.
31. Lochen ML, Rasmussen K. The Tromso study: physical fitness, self-reported physical activity, and their relationship to other coronary risk factors. J Epidemiol Comm Health 1992: 46: 103-107.
32. MacAuley D, McCrum EE, Stott C, Evans AE, Daly E, Trinick TR, Sweeney K, Boreham CAG. Physical activity, lipids, apolipoproteins and 1p(a) in the Northern Ireland Health and Activity Survey. Med Sci Sports Exerc 1996: 28: 720-736.
33. Marragat J, Elosua R, Coras MI, Molina Z, Rubies-Prat J, and Marathom investigators. Amount and intensity of physical activity, physical fitness and serum lipids in men. Am J Epidemiol 1996: 143: 562-569.
34. McMurray RG, Ainsworth BE, Harrell JS, Griggs TR, Williams OD. Is physical activity or aerobic power more influential on reducing cardiovascular risk factors? Med Sci Sports Exerc 1998: 30: 1521-1529.
35. Moller L, Kristensen TS. Plasma fibrinogen and ischaemic heart disease risk factors. Arterioscler Thromb 1991: 11: 344-350.
36. Reaven, GM. Role of insulin resistance in human disease (Syndrome X): an expanded definition. Annu Rev Med 1993: 44: 121-131.
37. Reaven PD, McPhilips JB, Barrett-Connor EL, Criqui MH. Leisure time exercise and lipid and lipoproteins in an older population. J Am Geriatr Soc 1990: 38: 847-854.
38. Sattar N, Tan CE, Han TS, Forster L, Lean ME, Shepard J, Packard CS. Associations of indices of adiposity with atherogenic lipoprotein subfractions. Int J Obes Relat Metab Disord 1998: 22: 432-439.
39. Schaefer EJ, Lamon-Fava S, Cohn SD, Schaefer MM, Ordovas JM, Castelli WP, Wilson PW. Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. J Lipid Res 1994: 35: 779-792.
40. Shaper AG, Wannamethee G. Physical activity and ischaemic heart disease in middle-aged British men. Br Heart J 1991: 66: 384-394.
41. 2max in epidemiological studies: a modification of the Astrand-Rhyming test. Med Sci Sports Exerc 1982: 14: 335-338.
42. St Amand J, Prud'homme D, Moorjani S, Nadeau A, Tremblay A, Bouchard C, Lupien PJ, Despres JP. Apolipoprotein E polymorphism and the relationships of physical fitness to plasma lipoprotein-lipids in men and women. Med Sci Sports Exerc 1999: 31: 692-697.
43. Superko HR. Did grandma give you heart disease? The new battle against coronary artery disease. Am J Cardiol 1998: 82 (9A): 34Q-46Q.
44. Thune I, Njolstad I, Lochen M L, Forde OH. Physical activity improves the metabolic risk profiles in men and women: the Tromso Study. Arch Intern Med 1998: 158: 1633-1640.
45. Warnick GR, Albers JJ. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high-density lipoprotein cholesterol. J Lipid Res 1978: 19: 65-76.
46. Wei M, Macera CA, Hornung CA, Blair SN. Changes in lipids associated with change in regular exercise in free-living men. J Clin Epidemiol 1997: 50: 1137-1142.
47. Williams PT, Krauss RM, Vranizan KM, Wood PDS. Changes in lipoprotein subfractions during diet-induced and exercise-induced weight loss in moderately overweight men. Circulation 1990: 81: 1293-1304.
48. Young DR, Steinhardt M. The importance of physical fitness versus physical activity for coronary artery disease risk factors: a cross-sectional analysis. Res Q Exerc Sport 1993: 64: 377-384.